| |
| |
|
| Insider
Information: |
Rice Derica W |
| Relationship: |
|
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
117,836 |
|
|
Indirect Shares
|
380,351 |
|
|
| Direct
Value |
$35,515,411 |
|
|
|
Indirect Value
|
$303,095,286 |
|
|
| Total
Shares |
498,187 |
|
|
| Total
Value |
$338,610,697 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP-Global Services an... |
2017-02-03 |
38,292 |
2017-02-03 |
374,958 |
Premium* |
|
|
Target Corp |
TGT |
Director |
2024-03-13 |
8,159 |
2007-09-12 |
0 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
EVP & President, CVS C... |
2020-02-28 |
50,922 |
2019-05-31 |
0 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Director |
|
0 |
2020-09-01 |
1,200 |
Premium* |
|
|
The Carlyle Group Inc |
CG |
|
2024-05-01 |
20,463 |
2024-05-01 |
4,193 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Sr. Vice President and CFO |
• – – |
2006-08-21 |
4 |
S |
$55.03 |
$77,042 |
D/D |
(1,400) |
12,410 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2010-02-03 |
4 |
S |
$35.15 |
$288,880 |
D/D |
(8,200) |
18,843 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. Vice President and CFO |
• – – |
2006-08-21 |
4 |
OE |
$34.60 |
$48,433 |
D/D |
1,400 |
13,810 |
|
- |
|
| LLY |
Eli Lilly & Co |
Sr. Vice President and CFO |
• – – |
2006-08-24 |
4 |
OE |
$34.60 |
$48,433 |
D/D |
1,400 |
13,810 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2010-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,999 |
40,999 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2011-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
82,942 |
82,942 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2012-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,924 |
113,497 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2013-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
52,947 |
106,792 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2014-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,781 |
89,356 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2014-09-04 |
4 |
OE |
$55.65 |
$1,284,235 |
D/D |
23,077 |
48,077 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2015-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,581 |
82,739 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2015-05-05 |
4 |
OE |
$52.54 |
$3,099,127 |
D/D |
57,108 |
88,474 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,685 |
56,560 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,463 |
58,443 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Sr. Vice President and CFOOff |
• – – |
2006-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,410 |
|
- |
|
| LLY |
Eli Lilly & Co |
Sr. Vice President and CFOOff |
• – – |
2006-05-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,292 |
|
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFOOff |
• – – |
2006-05-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
12,420 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2020-09-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,200 |
|
% |
|
| CG |
The Carlyle Group Inc |
Director |
– • – |
2021-03-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,193 |
|
- |
|
| LLY |
Eli Lilly & Co |
Sr. Vice President and CFO |
• – – |
2007-10-05 |
5 |
GD |
$0.00 |
$0 |
D/D |
32,658 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2009-03-03 |
5 |
GD |
$0.00 |
$0 |
D/D |
21,305 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2010-02-12 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,843 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2010-03-22 |
5 |
GD |
$0.00 |
$0 |
D/D |
10 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2011-02-24 |
5 |
GD |
$0.00 |
$0 |
D/D |
39,461 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2012-03-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
56,196 |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
